Genetic variants in complement pathway genes including complement factor H (CFH) [4-6], complement factor B (CFB)/complement component 2 (C2) [7], and complement component 3 (C3) [8-11] are established risks for developing AMD. This evidence concerns the gene C2 and age-related macular degeneration.